Elastomeric Infusion Pumps Sales

Elastomeric Infusion Pumps Sales Market Outlook

The global elastomeric infusion pumps market is currently valued at approximately USD 1.5 billion and is projected to grow at a compound annual growth rate (CAGR) of around 7.5% from 2025 to 2035. This growth is primarily driven by the increasing demand for efficient and patient-friendly drug delivery systems in various healthcare settings. The growing prevalence of chronic diseases, coupled with the rising geriatric population who require long-term medication, is significantly propelling the elastomeric infusion pumps market forward. Moreover, advancements in technology, such as the development of smart elastomeric pumps, are enhancing patient compliance and safety, thereby further expanding market growth. Increased awareness about the benefits of elastomeric infusion systems among healthcare professionals and patients alike is also contributing to the overall market expansion.

Growth Factor of the Market

One of the most critical growth factors for the elastomeric infusion pumps market is the rise in chronic disease management. As diseases like diabetes, cancer, and other debilitating conditions continue to rise, there is a growing need for effective pain management and drug administration solutions that elastomeric infusion pumps provide. Furthermore, the shift towards outpatient care and home healthcare scenarios has encouraged the adoption of these infusion systems due to their portability and user-friendly nature. Another significant factor is the technological advancements that have led to the development of advanced elastomeric infusion pumps with features such as dosage accuracy, customizable delivery rates, and even wireless connectivity for monitoring purposes. Additionally, government initiatives aimed at improving healthcare systems and promoting the use of advanced medical devices have also played a pivotal role in boosting market growth. Finally, an increasing emphasis on patient-centered care is prompting healthcare providers to opt for infusion solutions that offer greater convenience and improved patient experience.

Key Highlights of the Market

• The elastomeric infusion pumps market is expected to reach USD 2.9 billion by 2035.
• North America is anticipated to dominate the market due to advanced healthcare infrastructure and high therapeutic needs.
• Continuous rate elastomeric infusion pumps are the leading product type regarding market share.
• Homecare settings are emerging as a significant distribution channel for elastomeric infusion pumps.
• The rising prevalence of chronic illnesses is a major driver for market growth.

By Product Type

Continuous Rate Elastomeric Infusion Pumps:

Continuous rate elastomeric infusion pumps are designed to deliver a steady flow of medication, making them particularly effective for long-term treatments. These pumps are often preferred in clinical settings where a constant infusion rate is required, such as in the administration of analgesics or anesthetics. Their reliability and simplicity of use contribute to their popularity among healthcare professionals. Additionally, the ability to deliver a precise dosage over an extended time provides peace of mind for both the provider and the patient. The growing demand for pain management solutions in hospitals is further driving the adoption of continuous rate elastomeric infusion pumps, thus significantly contributing to the overall market growth.

Variable Rate Elastomeric Infusion Pumps:

Variable rate elastomeric infusion pumps offer the flexibility to adjust the drug delivery rate based on the patient’s needs or specific treatment protocols. This adaptability is particularly beneficial in scenarios where medication requirements may vary throughout the treatment process, such as in chemotherapy or acute pain management. The ability to tailor the infusion rate allows healthcare professionals to provide more personalized care, enhancing patient satisfaction and treatment outcomes. As modern medicine increasingly focuses on individualized treatment plans, the demand for variable rate elastomeric infusion pumps is expected to rise steadily, thereby supporting market growth.

Disposable Elastomeric Infusion Pumps:

Disposable elastomeric infusion pumps are designed for single use, which greatly reduces the risk of cross-contamination and infection. Their convenience and cost-effectiveness make them a favorable option in various healthcare settings, especially during outpatient treatments or home healthcare. These pumps are increasingly being adopted in pain management and antibiotic therapies, where sterile conditions are essential. The growing trend towards minimizing hospital stays and promoting outpatient care is further driving the demand for disposable elastomeric infusion pumps, thus contributing positively to the overall market growth. Additionally, awareness regarding hygiene and safety in medical devices plays a significant role in augmenting their adoption.

Reusable Elastomeric Infusion Pumps:

Reusable elastomeric infusion pumps are designed with durability in mind, providing an eco-friendly option for medication delivery. Their ability to be sterilized and used multiple times makes them a cost-effective choice in various healthcare environments. These pumps are often favored in settings where prolonged treatments are necessary, as they can significantly reduce waste and overall costs. Given the increasing focus on sustainability in healthcare, the adoption of reusable elastomeric infusion pumps is on the rise. Additionally, their versatility in delivering various types of medications adds to their appeal among healthcare professionals, thereby positively impacting market growth.

Ambulatory Elastomeric Infusion Pumps:

Ambulatory elastomeric infusion pumps offer patients the freedom to move around while receiving treatment, significantly enhancing their quality of life. These portable devices are particularly useful for patients who require long-term medication but do not wish to be confined to a hospital or clinic. They are increasingly being incorporated into pain management therapies and other chronic conditions, allowing for greater patient autonomy during treatment. The rising emphasis on patient-centered care and comfort is stimulating demand for ambulatory elastomeric infusion pumps, contributing to the overall growth of the market. Furthermore, advancements in design and technology continue to improve the functionality and ease of use of these devices, fostering further market adoption.

By Application

Pain Management:

Pain management is one of the primary applications of elastomeric infusion pumps, as these devices enable the continuous delivery of analgesics directly to patients. The flexibility and precision these pumps offer make them particularly effective for managing acute and chronic pain. In settings such as post-operative recovery, where pain control is crucial for patient comfort and recovery, elastomeric infusion pumps are increasingly being adopted. Moreover, advancements in pain management protocols emphasize a multimodal approach, further integrating elastomeric infusion pumps into treatment plans. The growing prevalence of conditions requiring pain relief, alongside the rising awareness among healthcare providers about the efficacy of elastomeric systems, is significantly driving this segment's growth.

Antibiotic/Antiviral Therapy:

Elastomeric infusion pumps play a vital role in administering antibiotics and antiviral medications, particularly in outpatient settings where patients require prolonged treatment. These pumps allow for precise dosing, which is essential for the effective treatment of infections and chronic conditions. As antibiotic resistance becomes a growing concern, there is increasing emphasis on ensuring proper dosing and adherence to treatment regimens, which elastomeric infusion pumps can facilitate. Furthermore, the rise in home healthcare settings has led to greater adoption of these pumps for managing therapies outside traditional hospital environments, providing patients with greater convenience and flexibility in their treatment.

Chemotherapy:

The use of elastomeric infusion pumps in chemotherapy has emerged as a vital application, particularly for cancer patients requiring continuous infusion of chemotherapeutic agents. These pumps allow for controlled delivery of medications, minimizing peaks and troughs in drug levels, which can be particularly beneficial in reducing side effects. Their portability increases patient compliance and comfort, enabling them to maintain their daily activities during treatment. As cancer rates continue to rise globally, the demand for effective and convenient chemotherapy administration options is expected to grow, thereby driving the elastomeric infusion pumps market forward in this application segment.

Others:

In addition to pain management, antibiotic, and chemotherapy applications, elastomeric infusion pumps are utilized in various other therapeutic areas, including nutrition delivery and hydration therapies. These pumps provide an efficient means of administering medications for conditions requiring specific nutrient delivery, such as in patients with gastrointestinal disorders. The versatility of elastomeric infusion pumps in catering to multiple therapeutic needs enhances their appeal among healthcare providers. As healthcare continues to evolve, the demand for flexible and efficient drug delivery systems is expected to rise, further contributing to the growth of this segment in the elastomeric infusion pumps market.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for elastomeric infusion pumps, as these healthcare institutions are the main providers of acute and chronic care. The comprehensive range of treatments provided, from pain management to chemotherapy, necessitates the availability of reliable infusion systems. Hospitals often prefer elastomeric pumps due to their precision in medication delivery, which is crucial for patient safety and treatment efficacy. Additionally, hospitals are increasingly adopting new technologies, further driving the demand for advanced elastomeric infusion pumps. The ongoing investments in hospital infrastructure and medical devices also bolster the growth of this distribution channel in the elastomeric infusion pumps market.

Clinics:

Clinics represent another significant distribution channel for elastomeric infusion pumps, particularly in outpatient settings. These facilities often cater to patients requiring ongoing treatments, such as pain management or antibiotic therapy, making the availability of efficient infusion systems critical. Clinics increasingly recognize the benefits of elastomeric infusion pumps in enhancing patient care and improving treatment outcomes. Their ease of use and ability to provide accurate dosages make them attractive options for healthcare providers. As outpatient care continues to grow in popularity, the demand for elastomeric infusion pumps in clinics is expected to increase steadily.

Homecare Settings:

Homecare settings have emerged as a vital distribution channel for elastomeric infusion pumps, driven by the growing trend towards patient-centered care and outpatient treatment options. The portability and user-friendly nature of elastomeric infusion pumps make them ideal for home healthcare, allowing patients to manage their therapies in comfortable environments. This shift not only enhances patient satisfaction but also reduces the burden on healthcare facilities. Furthermore, as the aging population requires more ongoing treatments in a home setting, the demand for elastomeric infusion pumps is expected to rise significantly, contributing to market growth in this distribution channel.

Others:

Other distribution channels, including online platforms and specialized medical supply stores, are also gaining traction in the elastomeric infusion pumps market. These channels provide consumers and healthcare providers with increased access to a variety of elastomeric infusion pump options. The growth of e-commerce and telemedicine has made it easier for patients to obtain the necessary medical devices without needing to visit healthcare facilities physically. As the trend towards digital healthcare continues, these alternative distribution channels are likely to play an increasingly important role in the overall market landscape, facilitating the wider adoption of elastomeric infusion pumps.

By Ingredient Type

Silicone:

Silicone is a predominant ingredient type used in the manufacturing of elastomeric infusion pumps due to its biocompatibility and flexibility. Silicone elastomers offer excellent resistance to temperature variations and can maintain consistent performance under different conditions, making them ideal for medical applications. Additionally, silicone-based devices are known for their durability and longevity, ensuring patient safety and reducing the need for frequent replacements. The growing focus on patient safety and the need for reliable drug delivery systems are driving the demand for silicone-based elastomeric infusion pumps, thus positively impacting market growth.

Thermoplastic Elastomer:

Thermoplastic elastomers (TPE) are increasingly being utilized in the production of elastomeric infusion pumps due to their excellent mechanical properties and ease of processing. TPEs combine the characteristics of rubber and thermoplastics, providing a versatile solution for medical devices. Their adaptability allows for the creation of lightweight and user-friendly infusion pumps that can cater to various therapeutic needs. As manufacturers continue to innovate and seek materials that enhance both performance and patient comfort, the adoption of thermoplastic elastomers in elastomeric infusion pumps is expected to grow significantly, further contributing to market expansion.

Polyisoprene:

Polyisoprene, known for its elasticity and biocompatibility, is another important ingredient type in elastomeric infusion pumps. This synthetic rubber is particularly valued for its hypoallergenic properties, making it suitable for patients with sensitive skin or allergies. Polyisoprene-based infusion systems provide reliable performance while ensuring patient comfort, which is vital in long-term therapies. As awareness of patient safety and comfort continues to rise, the use of polyisoprene in the manufacturing of elastomeric infusion pumps is expected to witness sustained growth in the market.

Others:

In addition to silicone, thermoplastic elastomers, and polyisoprene, several other materials are utilized in the production of elastomeric infusion pumps. These may include various blends and proprietary formulations designed to enhance specific performance characteristics or reduce manufacturing costs. Innovations in material science continue to drive the development of new compounds that can improve the overall functionality and safety of elastomeric infusion pumps. As manufacturers explore these alternative ingredient types, the market for elastomeric infusion pumps can expect a diversification of product offerings, contributing to overall growth and acceptance across various healthcare settings.

By Region

The North American region currently holds the largest share of the elastomeric infusion pumps market, accounting for approximately 40% of the total market value. This dominance can be attributed to the region's advanced healthcare infrastructure, high prevalence of chronic diseases, and significant investments in medical research and technology. Furthermore, the increasing adoption of home healthcare services is driving the demand for elastomeric infusion pumps in this region. The CAGR for the North American elastomeric infusion pumps market is projected to be around 8.2% over the next decade, reflecting a robust growth trajectory driven by innovations and an expanding patient population requiring advanced infusion solutions.

In contrast, the Asia Pacific region is anticipated to witness the fastest growth rate in the elastomeric infusion pumps market, attributed to the rising awareness of advanced medical devices and increasing healthcare expenditures. The region is experiencing an increase in chronic diseases, coupled with a growing aging population, which is significantly driving the demand for effective drug delivery systems. Countries like China and India are expected to lead this growth due to their vast population and improving healthcare systems. By 2035, the Asia Pacific region is projected to capture approximately 25% of the global elastomeric infusion pumps market share, reflecting a CAGR of around 9% during the forecast period.

Opportunities

One of the significant opportunities for growth in the elastomeric infusion pumps market lies in the increasing demand for home healthcare solutions. As the healthcare landscape evolves, more patients are opting for treatments that allow them to recuperate in the comfort of their own homes. Elastomeric infusion pumps serve as an ideal solution for this trend, enabling patients to receive medication and care without the need for constant hospital visits. The convenience and comfort of home healthcare are becoming increasingly attractive to patients and healthcare providers alike, fostering the market's expansion. Additionally, advancements in telehealth services and remote patient monitoring are likely to integrate seamlessly with elastomeric infusion pumps, creating a comprehensive ecosystem for patient care that can further spur growth in this sector.

Moreover, the growing focus on personalized medicine presents significant opportunities for elastomeric infusion pump manufacturers. As healthcare continues to shift towards individualized treatment plans, the need for devices that can deliver tailored medication regimens will increase. Elastomeric infusion pumps are uniquely positioned to meet these needs, thanks to their customizable dosing capabilities. By investing in research and development to innovate and enhance the features of elastomeric infusion pumps, manufacturers can capitalize on the trend toward personalized healthcare, thereby gaining a competitive edge in this evolving market landscape.

Threats

Despite the promising growth prospects, the elastomeric infusion pumps market faces several threats that could hinder its expansion. One of the primary challenges is the stringent regulatory environment surrounding the approval and use of medical devices. The complexities involved in obtaining regulatory approvals can delay the introduction of new products and innovations, potentially stiffling competition and market growth. Furthermore, the need for compliance with various international standards can impose significant burdens on manufacturers, particularly smaller companies that may lack the resources needed to navigate these regulatory hurdles. Additionally, the ongoing global supply chain disruptions could impact the availability of raw materials and components, further complicating the market landscape.

Another notable threat to the elastomeric infusion pumps market is the increasing competition from alternative drug delivery systems. As technology continues to advance, other forms of drug delivery, such as automated and electronic pumps, are becoming more prevalent. These alternatives may offer features such as enhanced monitoring, connectivity, and ease of use, potentially attracting patients and healthcare providers away from elastomeric infusion pumps. Consequently, elastomeric infusion pump manufacturers must continuously innovate and improve their offerings to remain competitive in an evolving landscape that increasingly prioritizes technological advancement and patient-centered care.

Competitor Outlook

• Hospira, Inc.
• Smiths Medical
• BD (Becton, Dickinson and Company)
• Medtronic PLC
• Fresenius Kabi AG
• Moog Inc.
• ICU Medical, Inc.
• Ambu A/S
• Terumo Corporation
• Alaris Medical Systems, Inc.
• Vygon S.A.
• Sun Pharmaceutical Industries Ltd.
• Halyard Health, Inc.
• Nipro Corporation
• Medline Industries, Inc.

The competitive landscape of the elastomeric infusion pumps market is characterized by a diverse range of players, each striving to innovate and capture market share. Leading companies such as Hospira, Inc. and Smiths Medical dominate the market, offering a wide range of elastomeric infusion pumps tailored to various therapeutic needs. These companies continuously invest in research and development to enhance their product offerings and maintain their competitive edge. Moreover, strategic partnerships and collaborations among industry players are becoming increasingly common, allowing companies to leverage complementary strengths and expand their market presence. Additionally, the increasing focus on patient safety and quality of care is propelling companies to prioritize the development of reliable and user-friendly infusion solutions.

Among the major players, BD (Becton, Dickinson and Company) stands out for its commitment to innovation and product development. The company has established itself as a leader in the medical device industry, including elastomeric infusion pumps. BD's robust portfolio, coupled with its focus on enhancing patient outcomes, ensures its strong position within the market. Similarly, Medtronic PLC is recognized for its advancements in infusion technology, often introducing cutting-edge solutions that cater to the evolving needs of healthcare providers and patients alike. This proactive approach to product development has contributed to Medtronic's sustained growth in the elastomeric infusion pumps segment.

Another notable player, Fresenius Kabi AG, emphasizes sustainability and efficiency in its elastomeric infusion pump offerings. The company's commitment to environmentally-friendly practices resonates well with the growing trend towards sustainable healthcare solutions. Furthermore, ICU Medical, Inc. has garnered attention for its integrated infusion therapy systems, which offer enhanced functionality and connectivity features, addressing the evolving demands of modern healthcare. As competition intensifies, companies are likely to continue investing in technology and innovation to differentiate their products and meet the changing needs of the healthcare ecosystem.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Ambu A/S
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Moog Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Vygon S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Hospira, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic PLC
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smiths Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fresenius Kabi AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 ICU Medical, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Nipro Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Terumo Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Halyard Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Medline Industries, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Alaris Medical Systems, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Sun Pharmaceutical Industries Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Elastomeric Infusion Pumps Sales Market, By Application
    • 6.1.1 Pain Management
    • 6.1.2 Antibiotic/Antiviral Therapy
    • 6.1.3 Chemotherapy
    • 6.1.4 Others
  • 6.2 Elastomeric Infusion Pumps Sales Market, By Product Type
    • 6.2.1 Continuous Rate Elastomeric Infusion Pumps
    • 6.2.2 Variable Rate Elastomeric Infusion Pumps
    • 6.2.3 Disposable Elastomeric Infusion Pumps
    • 6.2.4 Reusable Elastomeric Infusion Pumps
    • 6.2.5 Ambulatory Elastomeric Infusion Pumps
  • 6.3 Elastomeric Infusion Pumps Sales Market, By Ingredient Type
    • 6.3.1 Silicone
    • 6.3.2 Thermoplastic Elastomer
    • 6.3.3 Polyisoprene
    • 6.3.4 Others
  • 6.4 Elastomeric Infusion Pumps Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Homecare Settings
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Elastomeric Infusion Pumps Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Elastomeric Infusion Pumps Sales market is categorized based on

By Product Type

• Continuous Rate Elastomeric Infusion Pumps
• Variable Rate Elastomeric Infusion Pumps
• Disposable Elastomeric Infusion Pumps
• Reusable Elastomeric Infusion Pumps
• Ambulatory Elastomeric Infusion Pumps

By Application

• Pain Management
• Antibiotic/Antiviral Therapy
• Chemotherapy
• Others

By Distribution Channel

• Hospitals
• Clinics
• Homecare Settings
• Others

By Ingredient Type

• Silicone
• Thermoplastic Elastomer
• Polyisoprene
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Hospira, Inc.
• Smiths Medical
• BD (Becton, Dickinson and Company)
• Medtronic PLC
• Fresenius Kabi AG
• Moog Inc.
• ICU Medical, Inc.
• Ambu A/S
• Terumo Corporation
• Alaris Medical Systems, Inc.
• Vygon S.A.
• Sun Pharmaceutical Industries Ltd.
• Halyard Health, Inc.
• Nipro Corporation
• Medline Industries, Inc.